NUS — NU Skin Enterprises Balance Sheet
0.000.00%
- $285.09m
- $488.96m
- $1.73bn
- 90
- 89
- 78
- 98
Annual balance sheet for NU Skin Enterprises, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 457 | 356 | 280 | 270 | 202 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 63.4 | 41.3 | 47.4 | 72.9 | 50.8 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 903 | 873 | 760 | 702 | 539 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 623 | 575 | 558 | 534 | 462 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,957 | 1,906 | 1,821 | 1,806 | 1,469 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 543 | 530 | 359 | 329 | 297 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,063 | 994 | 924 | 984 | 817 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 894 | 913 | 897 | 822 | 651 |
Total Liabilities & Shareholders' Equity | 1,957 | 1,906 | 1,821 | 1,806 | 1,469 |
Total Common Shares Outstanding |